William John Fraser Goldie

William John Fraser Goldie

Presidente presso OxThera AB

Health Technology

Provenienza dei contatti di primo grado di William John Fraser Goldie

EntitàTipo di entitàSettore Industriale
2
Holding Company Pharmaceuticals: Generic 2

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a William John Fraser Goldie tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
KARO PHARMA AB (PUBL) Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Mats-Olof Wallin

Director/Board Member

Director of Finance/CFO

BIOINVENT INTERNATIONAL AB Biotechnology

Edith Olga Elisabeth Lindner

Director/Board Member

BIOTAGE AB Medical Specialties

Mats-Olof Wallin

Director of Finance/CFO

University of Uppsala College/University

Edith Olga Elisabeth Lindner

Mats-Olof Wallin

Masters Business Admin

Undergraduate Degree

Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Corporate Officer/Principal

CALLIDITAS THERAPEUTICS AB Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Director/Board Member

Royal Institute of Technology College/University

Edith Olga Elisabeth Lindner

Graduate Degree

Miscellaneous Commercial Services

Edith Olga Elisabeth Lindner

Corporate Officer/Principal

Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Corporate Officer/Principal

Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Director/Board Member

Biosource Europe AB

Edith Olga Elisabeth Lindner

Director/Board Member

SWEDISH ORPHAN BIOVITRUM AB Pharmaceuticals: Major

Mats-Olof Wallin

Director of Finance/CFO

Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Director/Board Member

Pharmaceuticals: Major

Edith Olga Elisabeth Lindner

Chairman

Statistiche

Distribuzione geografica

Svezia 15
Stati Uniti 2
Regno Unito 2

Settori

Health Technology 12
Consumer Services 3
Finance 2
Commercial Services 2

Posizioni

Director/Board Member 6
Corporate Officer/Principal 4
Director of Finance/CFO 4
Public Communications Contact 3
Chief Executive Officer 2